NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/01/2024
Voltar para busca
Dado oficial do USPTO
OVATURE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
23/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
26/03/2020
Data de registro
23/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/01/2024
Última transação
23/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
17/11/2023
Primeiro uso no comércio
17/11/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
Washington DC, DC, US
Examinador
FALK, ERIN
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Global Alzheimer's Platform Foundation Inc.
Representantes
Christopher A. Proskey BROWNWINICK LAW FIRM
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Promoting public awareness of Alzheimer's and other neurological and central nervous system diseases and issues related thereto in the nature of patient registriespatient researchpatient advocacy and patient fundraising efforts; promoting public awareness of health care issues for patients with Alzheimer's and other neurological and central nervous system diseasesthe importance of patient registration on Alzheimer's and other neurological and central nervous system disease registries; charitable servicesorganizing and developing programs that aim to improve the lives of patients with Alzheimer's and other neurological and central nervous system disease patientstheir caregivers and families; charitable business servicesadministration of programs for enabling participants to receive services for Alzheimer's and other neurological and central nervous system disease patientstheir caregivers and families; recruitment of participants for neuroscience clinical research; maintaining a registry of participants for neuroscience clinical research relating to the treatment and prevention of brain disease; promoting participation in clinical trials and research in the neuroscience field; recruitment advertising servicesadvertising clinical trials for the purpose of recruiting patients and placing patients for participation in clinical trials in the neuroscience field
Classe 42
Conducting clinical trials and research for others in the field of Alzheimer's and other neurological and central nervous system diseases; medical clinic servicesconducting of clinical trials and research for others in the field of Alzheimer's and other neurological and central nervous system diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
23/01/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
20/12/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
19/12/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
28/11/2023
IUAF
USE AMENDMENT FILED
17/11/2023
EISU
TEAS STATEMENT OF USE RECEIVED
17/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20/05/2023
EX5G
SOU EXTENSION 5 GRANTED
19/05/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
19/05/2023
EXT5
SOU EXTENSION 5 FILED
16/05/2023
EEXT
SOU TEAS EXTENSION RECEIVED
16/05/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/11/2022
EX4G
SOU EXTENSION 4 GRANTED
15/11/2022
EXT4
SOU EXTENSION 4 FILED
15/11/2022
EEXT
SOU TEAS EXTENSION RECEIVED
15/11/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/04/2022
EX3G
SOU EXTENSION 3 GRANTED
27/04/2022
EXT3
SOU EXTENSION 3 FILED
27/04/2022
EEXT
SOU TEAS EXTENSION RECEIVED
27/04/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/11/2021
EX2G
SOU EXTENSION 2 GRANTED
15/11/2021
EXT2
SOU EXTENSION 2 FILED
15/11/2021
EEXT
SOU TEAS EXTENSION RECEIVED
15/11/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/05/2021
EX1G
SOU EXTENSION 1 GRANTED
29/04/2021
EXT1
SOU EXTENSION 1 FILED
29/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
29/04/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/09/2020
PUBO
PUBLISHED FOR OPPOSITION
22/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/08/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
20/08/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/08/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
20/08/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/07/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/07/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/07/2020
GNRT
NON-FINAL ACTION E-MAILED
08/07/2020
CNRT
NON-FINAL ACTION WRITTEN
08/07/2020
DOCK
ASSIGNED TO EXAMINER
17/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2020
NWAP
NEW APPLICATION ENTERED
30/03/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OVATURE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.